We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01733914
Recruitment Status : Completed
First Posted : November 27, 2012
Last Update Posted : April 14, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
According to traditional Chinese medical theories, a variety of acupuncture formulas can treat diseases such as pain. For example, stimulating acupoints either local or distal to the pain site has been proposed under some conditions. We hypothesize that stimulating acupoints contralateral to the pain site can successfully treat chronic shoulder pain.

Condition or disease Intervention/treatment Phase
Shoulder Pain Procedure: Acupuncture Other: Control Phase 2

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Phase II Study of Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain
Study Start Date : September 2011
Primary Completion Date : April 2013
Study Completion Date : August 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acupuncture
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Acupuncture
Experimental group
Procedure: Acupuncture
Acupuncture in the following acupoints on the contralateral side of pain site: Jiantong, Zhongzhu, Houxi, and Quchi. The patient will receive 5 treatments (each lasts 30 min) per week for four weeks.
Sham Comparator: Waiting list
Control group
Other: Control
Patients in the waiting list group received conventional orthopaedic therapy including physical exercise, heat or cold therapy. 50 mg diclofenac daily could be taken when the patient suffered from the pain. Injections or cortisone applications of any kind were not allowed.

Outcome Measures

Primary Outcome Measures :
  1. Visual analogue scale (VAS) [ Time Frame: before and 2, 4, 8 and 16 weeks after treatment start ]
    Pain assessment

Secondary Outcome Measures :
  1. The MOS item short from health survey (SF-36) [ Time Frame: before and 8 and 16 weeks after treatment start ]
    Quality of life assessment

  2. Constant-Murley score [ Time Frame: before and 2, 4, 8 and 16 weeks after treatment start ]
    shoulder motion score

  3. DASH score [ Time Frame: before and 2, 4, 8 and 16 weeks after treatment start ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   25 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Uni-lateral shoulder pain for 6 weeks to 2 years
  • VAS score ≤ 50
  • 25-65 years of age
  • Positive Neer's or Hawkins' signs
  • Accept the informed consent

Exclusion Criteria:

  • Shoulder pain of neurological origins
  • Shoulder pain of neck origins
  • Systematic arthritis
  • Wrist problems
  • Previous shoulder, arm, neck or chest fractures or surgeries
  • Mental diseases
  • Pregnancy
  • Inability to work for more than 3 months before treatment
  • Diabetes
  • Coagulative dysfunction
  • Corticosterone or physicotherapy experience on the affected shoulder in the last 6 months
  • Failure to accept the informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01733914

China, Sichuan
Province Hospital of Integrative Chinese and Western Medicine, Sichuan
Chengdu, Sichuan, China, 100191
Sponsors and Collaborators
Peking University
University of Maryland
Principal Investigator: Ming Yi, PhD Peking University
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Ming Yi, PhD, principle investigator, Dr, Peking University
ClinicalTrials.gov Identifier: NCT01733914     History of Changes
Other Study ID Numbers: 2007CB512501
First Posted: November 27, 2012    Key Record Dates
Last Update Posted: April 14, 2015
Last Verified: May 2014

Keywords provided by Ming Yi, PhD, principle investigator, Peking University:
shoulder pain

Additional relevant MeSH terms:
Shoulder Pain
Joint Diseases
Musculoskeletal Diseases
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms